SSNA1
Basic information
Region (hg38): 9:137188660-137190370
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SSNA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in SSNA1
This is a list of pathogenic ClinVar variants found in the SSNA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-137188772-G-T | not specified | Uncertain significance (Nov 09, 2024) | ||
9-137188776-A-C | not specified | Uncertain significance (May 24, 2024) | ||
9-137189129-A-G | not specified | Uncertain significance (Oct 04, 2024) | ||
9-137189131-A-C | not specified | Uncertain significance (Feb 24, 2025) | ||
9-137189185-A-G | not specified | Uncertain significance (Jul 26, 2023) | ||
9-137189210-C-T | not specified | Uncertain significance (Apr 06, 2022) | ||
9-137189233-A-T | not specified | Uncertain significance (Jun 29, 2022) | ||
9-137189237-T-C | not specified | Uncertain significance (Dec 05, 2022) | ||
9-137189246-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
9-137189251-G-A | not specified | Uncertain significance (Mar 16, 2022) | ||
9-137189260-C-T | not specified | Uncertain significance (Jun 21, 2022) | ||
9-137189818-C-G | not specified | Uncertain significance (Dec 06, 2021) | ||
9-137189826-C-G | not specified | Uncertain significance (Jun 07, 2024) | ||
9-137189850-A-G | not specified | Uncertain significance (Mar 12, 2024) | ||
9-137189865-C-G | not specified | Uncertain significance (Nov 09, 2024) | ||
9-137189871-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
9-137189900-G-A | not specified | Uncertain significance (Jun 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SSNA1 | protein_coding | protein_coding | ENST00000322310 | 3 | 1724 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000334 | 0.384 | 125267 | 0 | 142 | 125409 | 0.000566 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.601 | 81 | 67.2 | 1.21 | 0.00000319 | 769 |
Missense in Polyphen | 12 | 14.04 | 0.85472 | 193 | ||
Synonymous | -0.961 | 37 | 30.3 | 1.22 | 0.00000158 | 226 |
Loss of Function | -0.104 | 5 | 4.76 | 1.05 | 2.01e-7 | 58 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0107 | 0.0101 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000349 | 0.000318 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000715 | 0.000653 |
dbNSFP
Source:
- Pathway
- miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance
(Consensus)
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.352
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 52.85
Haploinsufficiency Scores
- pHI
- 0.217
- hipred
- Y
- hipred_score
- 0.514
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ssna1
- Phenotype
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;intraciliary transport;ciliary receptor clustering involved in smoothened signaling pathway;ciliary basal body-plasma membrane docking
- Cellular component
- nucleus;centrosome;cytosol;ciliary basal body
- Molecular function
- protein binding;identical protein binding